Skip to content

The Establishment of Large-sample Database of Multiple-MRI/Gene/Cognition

The Establishment of Large-sample Database of Multiple-MRI/Gene/Cognition

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02144467
Enrollment
5000
Registered
2014-05-22
Start date
2014-05-08
Completion date
2022-08-02
Last updated
2022-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

Multiple-MRI, Gene, Cognition

Brief summary

Aim to establish a large-sample database of Multiple-MRI/Gene/Cognition for healthy Chinese (sample number, 5000; age, 6-70 years). This is a fundamental but very necessary work for future researches such as development, aging, relation of gene and behavior, relation of gene and neuroimaging, relation of behavior and neuroimaging. Importantly, this work will provide a norm for researches on psychological or neurological patients. This large-sample will be shared with world-wide researchers.

Detailed description

A part of data have been used in a publication which is preparing to submit.

Interventions

DEVICEMRI

fMRI, sMRI, ASL and DTI

Sponsors

Hangzhou Normal University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
6 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy Chinese * Age: 6-70 years old * Right handed * No smoking or alcoholic addiction

Exclusion criteria

* Psychological or neurological patients * Hypertension or cardiopathy patients * Pregnant woman * Take medicine or drink tea/coffee before scanning-

Design outcomes

Primary

MeasureTime frameDescription
The distribution of the amplitude of blood oxygenation level dependent(BOLD) signal in healthy subjectsup to 15 monthsThe amplitude of BOLD-functional magnetic resonance imaging(fMRI) signal is a common measure to estimate the brain activity during resting-state. We try to establish its distribution on healthy subjects, which could be a control to examine abnormal brain function in patients.

Countries

China

Contacts

Primary ContactJue Wang, PHD
juefirst@163.com

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026